nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitotane—FDX1—Metabolism of steroid hormones and vitamin D—HSD17B12—peripheral nervous system neoplasm	0.0178	0.373	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of steroid hormones and vitamin D—HSD17B12—peripheral nervous system neoplasm	0.00634	0.133	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of steroid hormones and vitamin D—HSD17B12—peripheral nervous system neoplasm	0.00542	0.114	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.00182	0.0383	CbGpPWpGaD
Mitotane—SHBG—Nongenotropic Androgen signaling—HRAS—peripheral nervous system neoplasm	0.00123	0.0258	CbGpPWpGaD
Mitotane—FDX1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.0012	0.0252	CbGpPWpGaD
Mitotane—SHBG—Nongenotropic Androgen signaling—AKT1—peripheral nervous system neoplasm	0.00109	0.0228	CbGpPWpGaD
Mitotane—Flushing—Etoposide—peripheral nervous system neoplasm	0.00106	0.00111	CcSEcCtD
Mitotane—Hypertension—Vincristine—peripheral nervous system neoplasm	0.00106	0.00111	CcSEcCtD
Mitotane—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.00105	0.0011	CcSEcCtD
Mitotane—Angiopathy—Etoposide—peripheral nervous system neoplasm	0.00103	0.00109	CcSEcCtD
Mitotane—Infection—Alitretinoin—peripheral nervous system neoplasm	0.00103	0.00108	CcSEcCtD
Mitotane—Mental disability—Doxorubicin—peripheral nervous system neoplasm	0.00102	0.00107	CcSEcCtD
Mitotane—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.00102	0.00107	CcSEcCtD
Mitotane—Shock—Alitretinoin—peripheral nervous system neoplasm	0.00102	0.00107	CcSEcCtD
Mitotane—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.00102	0.00107	CcSEcCtD
Mitotane—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00102	0.00107	CcSEcCtD
Mitotane—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.00102	0.00107	CcSEcCtD
Mitotane—Tremor—Cisplatin—peripheral nervous system neoplasm	0.00102	0.00107	CcSEcCtD
Mitotane—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00101	0.00106	CcSEcCtD
Mitotane—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00101	0.00106	CcSEcCtD
Mitotane—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.00101	0.00106	CcSEcCtD
Mitotane—Anaemia—Cisplatin—peripheral nervous system neoplasm	0.001	0.00105	CcSEcCtD
Mitotane—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000996	0.00105	CcSEcCtD
Mitotane—Infection—Vincristine—peripheral nervous system neoplasm	0.000994	0.00104	CcSEcCtD
Mitotane—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000991	0.00104	CcSEcCtD
Mitotane—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.00099	0.00104	CcSEcCtD
Mitotane—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000983	0.00103	CcSEcCtD
Mitotane—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000983	0.00103	CcSEcCtD
Mitotane—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.000981	0.00103	CcSEcCtD
Mitotane—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.000979	0.00103	CcSEcCtD
Mitotane—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000973	0.00102	CcSEcCtD
Mitotane—Dysgeusia—Etoposide—peripheral nervous system neoplasm	0.000972	0.00102	CcSEcCtD
Mitotane—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00097	0.00102	CcSEcCtD
Mitotane—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.00097	0.00102	CcSEcCtD
Mitotane—Pain—Dactinomycin—peripheral nervous system neoplasm	0.000957	0.00101	CcSEcCtD
Mitotane—Anorexia—Vincristine—peripheral nervous system neoplasm	0.000954	0.001	CcSEcCtD
Mitotane—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000945	0.000992	CcSEcCtD
Mitotane—Lethargy—Epirubicin—peripheral nervous system neoplasm	0.000943	0.00099	CcSEcCtD
Mitotane—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000937	0.000984	CcSEcCtD
Mitotane—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000937	0.000984	CcSEcCtD
Mitotane—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000935	0.000982	CcSEcCtD
Mitotane—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000932	0.000979	CcSEcCtD
Mitotane—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000925	0.000971	CcSEcCtD
Mitotane—Osteoarthritis—Epirubicin—peripheral nervous system neoplasm	0.000924	0.00097	CcSEcCtD
Mitotane—Diplopia—Epirubicin—peripheral nervous system neoplasm	0.000924	0.00097	CcSEcCtD
Mitotane—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000923	0.000969	CcSEcCtD
Mitotane—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000923	0.000969	CcSEcCtD
Mitotane—Anaemia—Etoposide—peripheral nervous system neoplasm	0.000918	0.000964	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000916	0.000962	CcSEcCtD
Mitotane—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000914	0.00096	CcSEcCtD
Mitotane—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000913	0.000959	CcSEcCtD
Mitotane—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000906	0.000951	CcSEcCtD
Mitotane—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000906	0.000951	CcSEcCtD
Mitotane—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000902	0.000948	CcSEcCtD
Mitotane—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000898	0.000943	CcSEcCtD
Mitotane—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000896	0.000941	CcSEcCtD
Mitotane—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000892	0.000937	CcSEcCtD
Mitotane—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000888	0.000932	CcSEcCtD
Mitotane—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000885	0.000929	CcSEcCtD
Mitotane—Infection—Cisplatin—peripheral nervous system neoplasm	0.000879	0.000923	CcSEcCtD
Mitotane—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000878	0.000922	CcSEcCtD
Mitotane—Lethargy—Doxorubicin—peripheral nervous system neoplasm	0.000873	0.000916	CcSEcCtD
Mitotane—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000871	0.000915	CcSEcCtD
Mitotane—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000871	0.000915	CcSEcCtD
Mitotane—Rash—Topotecan—peripheral nervous system neoplasm	0.000871	0.000914	CcSEcCtD
Mitotane—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00087	0.000913	CcSEcCtD
Mitotane—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.00087	0.000913	CcSEcCtD
Mitotane—Ataxia—Epirubicin—peripheral nervous system neoplasm	0.000869	0.000913	CcSEcCtD
Mitotane—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000867	0.000911	CcSEcCtD
Mitotane—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000866	0.000909	CcSEcCtD
Mitotane—Headache—Topotecan—peripheral nervous system neoplasm	0.000865	0.000908	CcSEcCtD
Mitotane—Rash—Tretinoin—peripheral nervous system neoplasm	0.000864	0.000907	CcSEcCtD
Mitotane—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000864	0.000907	CcSEcCtD
Mitotane—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000864	0.000907	CcSEcCtD
Mitotane—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000863	0.000906	CcSEcCtD
Mitotane—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000863	0.000906	CcSEcCtD
Mitotane—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00086	0.000903	CcSEcCtD
Mitotane—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000859	0.000902	CcSEcCtD
Mitotane—Headache—Tretinoin—peripheral nervous system neoplasm	0.000858	0.000901	CcSEcCtD
Mitotane—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000858	0.000901	CcSEcCtD
Mitotane—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000857	0.0009	CcSEcCtD
Mitotane—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000855	0.000898	CcSEcCtD
Mitotane—Pain—Vincristine—peripheral nervous system neoplasm	0.000855	0.000898	CcSEcCtD
Mitotane—Osteoarthritis—Doxorubicin—peripheral nervous system neoplasm	0.000855	0.000898	CcSEcCtD
Mitotane—Diplopia—Doxorubicin—peripheral nervous system neoplasm	0.000855	0.000898	CcSEcCtD
Mitotane—Rash—Melphalan—peripheral nervous system neoplasm	0.000853	0.000895	CcSEcCtD
Mitotane—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000852	0.000894	CcSEcCtD
Mitotane—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.000844	0.000886	CcSEcCtD
Mitotane—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000843	0.000885	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000839	0.000881	CcSEcCtD
Mitotane—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.000835	0.000877	CcSEcCtD
Mitotane—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000827	0.000868	CcSEcCtD
Mitotane—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000825	0.000866	CcSEcCtD
Mitotane—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000821	0.000862	CcSEcCtD
Mitotane—Nausea—Topotecan—peripheral nervous system neoplasm	0.00082	0.000861	CcSEcCtD
Mitotane—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000817	0.000858	CcSEcCtD
Mitotane—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.000815	0.000856	CcSEcCtD
Mitotane—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000814	0.000854	CcSEcCtD
Mitotane—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000814	0.000854	CcSEcCtD
Mitotane—FDX1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000812	0.017	CbGpPWpGaD
Mitotane—Infection—Etoposide—peripheral nervous system neoplasm	0.000805	0.000845	CcSEcCtD
Mitotane—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.000804	0.000844	CcSEcCtD
Mitotane—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000803	0.000844	CcSEcCtD
Mitotane—Nausea—Melphalan—peripheral nervous system neoplasm	0.000803	0.000843	CcSEcCtD
Mitotane—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000794	0.000834	CcSEcCtD
Mitotane—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000793	0.000833	CcSEcCtD
Mitotane—CYP11B1—Corticotropin-releasing hormone—GNAS—peripheral nervous system neoplasm	0.000792	0.0166	CbGpPWpGaD
Mitotane—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000791	0.00083	CcSEcCtD
Mitotane—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000787	0.000826	CcSEcCtD
Mitotane—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000781	0.00082	CcSEcCtD
Mitotane—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000773	0.000811	CcSEcCtD
Mitotane—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000772	0.000811	CcSEcCtD
Mitotane—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000769	0.000807	CcSEcCtD
Mitotane—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000766	0.000804	CcSEcCtD
Mitotane—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000765	0.000803	CcSEcCtD
Mitotane—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000764	0.000802	CcSEcCtD
Mitotane—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000757	0.000795	CcSEcCtD
Mitotane—Pain—Cisplatin—peripheral nervous system neoplasm	0.000756	0.000794	CcSEcCtD
Mitotane—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000754	0.000792	CcSEcCtD
Mitotane—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000747	0.000784	CcSEcCtD
Mitotane—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000745	0.000782	CcSEcCtD
Mitotane—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000737	0.000774	CcSEcCtD
Mitotane—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000729	0.000765	CcSEcCtD
Mitotane—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000728	0.000764	CcSEcCtD
Mitotane—Somnolence—Etoposide—peripheral nervous system neoplasm	0.00072	0.000756	CcSEcCtD
Mitotane—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000718	0.000754	CcSEcCtD
Mitotane—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000712	0.000748	CcSEcCtD
Mitotane—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000712	0.000748	CcSEcCtD
Mitotane—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000712	0.000748	CcSEcCtD
Mitotane—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000712	0.000748	CcSEcCtD
Mitotane—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00071	0.000746	CcSEcCtD
Mitotane—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000706	0.000741	CcSEcCtD
Mitotane—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000704	0.00074	CcSEcCtD
Mitotane—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.0007	0.000735	CcSEcCtD
Mitotane—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000699	0.000734	CcSEcCtD
Mitotane—Pain—Etoposide—peripheral nervous system neoplasm	0.000693	0.000728	CcSEcCtD
Mitotane—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000691	0.000726	CcSEcCtD
Mitotane—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000686	0.000721	CcSEcCtD
Mitotane—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000684	0.000719	CcSEcCtD
Mitotane—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000679	0.000713	CcSEcCtD
Mitotane—CYP11A1—Corticotropin-releasing hormone—GNAS—peripheral nervous system neoplasm	0.000678	0.0142	CbGpPWpGaD
Mitotane—FDX1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.000675	0.0142	CbGpPWpGaD
Mitotane—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000674	0.000707	CcSEcCtD
Mitotane—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000668	0.000701	CcSEcCtD
Mitotane—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000665	0.000698	CcSEcCtD
Mitotane—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000662	0.000695	CcSEcCtD
Mitotane—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00066	0.000693	CcSEcCtD
Mitotane—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000659	0.000692	CcSEcCtD
Mitotane—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000659	0.000692	CcSEcCtD
Mitotane—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000659	0.000692	CcSEcCtD
Mitotane—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000655	0.000687	CcSEcCtD
Mitotane—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000654	0.000687	CcSEcCtD
Mitotane—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000652	0.000684	CcSEcCtD
Mitotane—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00065	0.000683	CcSEcCtD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000649	0.0136	CbGpPWpGaD
Mitotane—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000641	0.000673	CcSEcCtD
Mitotane—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000639	0.000671	CcSEcCtD
Mitotane—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000636	0.000668	CcSEcCtD
Mitotane—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000635	0.000666	CcSEcCtD
Mitotane—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000631	0.000663	CcSEcCtD
Mitotane—Rash—Vincristine—peripheral nervous system neoplasm	0.000631	0.000662	CcSEcCtD
Mitotane—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00063	0.000662	CcSEcCtD
Mitotane—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000628	0.00066	CcSEcCtD
Mitotane—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000628	0.00066	CcSEcCtD
Mitotane—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000627	0.000658	CcSEcCtD
Mitotane—Headache—Vincristine—peripheral nervous system neoplasm	0.000627	0.000658	CcSEcCtD
Mitotane—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000623	0.000654	CcSEcCtD
Mitotane—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000617	0.000647	CcSEcCtD
Mitotane—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000616	0.000647	CcSEcCtD
Mitotane—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000605	0.000635	CcSEcCtD
Mitotane—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000598	0.000627	CcSEcCtD
Mitotane—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000597	0.000627	CcSEcCtD
Mitotane—Nausea—Vincristine—peripheral nervous system neoplasm	0.000594	0.000624	CcSEcCtD
Mitotane—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000593	0.000623	CcSEcCtD
Mitotane—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000592	0.000621	CcSEcCtD
Mitotane—FDX1—Metabolism—GNS—peripheral nervous system neoplasm	0.000587	0.0123	CbGpPWpGaD
Mitotane—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000584	0.000613	CcSEcCtD
Mitotane—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000581	0.00061	CcSEcCtD
Mitotane—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000581	0.00061	CcSEcCtD
Mitotane—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.00058	0.000609	CcSEcCtD
Mitotane—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.00058	0.000609	CcSEcCtD
Mitotane—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.00057	0.000599	CcSEcCtD
Mitotane—FDX1—Metabolism—NME1—peripheral nervous system neoplasm	0.000563	0.0118	CbGpPWpGaD
Mitotane—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000562	0.000591	CcSEcCtD
Mitotane—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.00056	0.000588	CcSEcCtD
Mitotane—Rash—Cisplatin—peripheral nervous system neoplasm	0.000558	0.000586	CcSEcCtD
Mitotane—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000557	0.000585	CcSEcCtD
Mitotane—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000557	0.000584	CcSEcCtD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000556	0.0117	CbGpPWpGaD
Mitotane—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000554	0.000582	CcSEcCtD
Mitotane—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000553	0.000581	CcSEcCtD
Mitotane—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000549	0.000577	CcSEcCtD
Mitotane—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000545	0.000572	CcSEcCtD
Mitotane—FDX1—Metabolism—COX2—peripheral nervous system neoplasm	0.000542	0.0114	CbGpPWpGaD
Mitotane—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000537	0.000564	CcSEcCtD
Mitotane—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000536	0.000563	CcSEcCtD
Mitotane—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000525	0.000552	CcSEcCtD
Mitotane—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000525	0.000551	CcSEcCtD
Mitotane—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000518	0.000544	CcSEcCtD
Mitotane—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000515	0.000541	CcSEcCtD
Mitotane—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000515	0.000541	CcSEcCtD
Mitotane—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000514	0.00054	CcSEcCtD
Mitotane—Rash—Etoposide—peripheral nervous system neoplasm	0.000511	0.000537	CcSEcCtD
Mitotane—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00051	0.000536	CcSEcCtD
Mitotane—Headache—Etoposide—peripheral nervous system neoplasm	0.000508	0.000533	CcSEcCtD
Mitotane—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000504	0.00053	CcSEcCtD
Mitotane—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.0005	0.000525	CcSEcCtD
Mitotane—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000485	0.00051	CcSEcCtD
Mitotane—Nausea—Etoposide—peripheral nervous system neoplasm	0.000481	0.000505	CcSEcCtD
Mitotane—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000481	0.000505	CcSEcCtD
Mitotane—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000476	0.0005	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000471	0.000494	CcSEcCtD
Mitotane—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000463	0.000486	CcSEcCtD
Mitotane—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000458	0.000481	CcSEcCtD
Mitotane—Infection—Epirubicin—peripheral nervous system neoplasm	0.000451	0.000474	CcSEcCtD
Mitotane—Shock—Epirubicin—peripheral nervous system neoplasm	0.000447	0.000469	CcSEcCtD
Mitotane—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000445	0.000468	CcSEcCtD
Mitotane—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000445	0.000467	CcSEcCtD
Mitotane—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000445	0.000467	CcSEcCtD
Mitotane—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000441	0.000463	CcSEcCtD
Mitotane—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000435	0.000457	CcSEcCtD
Mitotane—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000433	0.000455	CcSEcCtD
Mitotane—CYP11B1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000428	0.00898	CbGpPWpGaD
Mitotane—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000424	0.000446	CcSEcCtD
Mitotane—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000424	0.000445	CcSEcCtD
Mitotane—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000418	0.000438	CcSEcCtD
Mitotane—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000414	0.000434	CcSEcCtD
Mitotane—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000412	0.000433	CcSEcCtD
Mitotane—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000412	0.000432	CcSEcCtD
Mitotane—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000408	0.000429	CcSEcCtD
Mitotane—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000408	0.000428	CcSEcCtD
Mitotane—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000404	0.000424	CcSEcCtD
Mitotane—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000401	0.000421	CcSEcCtD
Mitotane—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.0004	0.00042	CcSEcCtD
Mitotane—CYP11B1—Corticotropin-releasing hormone—CASP3—peripheral nervous system neoplasm	0.000395	0.00829	CbGpPWpGaD
Mitotane—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000395	0.000415	CcSEcCtD
Mitotane—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000393	0.000412	CcSEcCtD
Mitotane—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000392	0.000412	CcSEcCtD
Mitotane—Pain—Epirubicin—peripheral nervous system neoplasm	0.000388	0.000408	CcSEcCtD
Mitotane—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000377	0.000396	CcSEcCtD
Mitotane—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000374	0.000393	CcSEcCtD
Mitotane—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000374	0.000392	CcSEcCtD
Mitotane—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.00037	0.000388	CcSEcCtD
Mitotane—CYP11A1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000366	0.00769	CbGpPWpGaD
Mitotane—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000365	0.000384	CcSEcCtD
Mitotane—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000363	0.000381	CcSEcCtD
Mitotane—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000359	0.000377	CcSEcCtD
Mitotane—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000359	0.000377	CcSEcCtD
Mitotane—FDX1—Metabolism—ENO2—peripheral nervous system neoplasm	0.000356	0.00746	CbGpPWpGaD
Mitotane—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000346	0.000364	CcSEcCtD
Mitotane—CYP11A1—Corticotropin-releasing hormone—CASP3—peripheral nervous system neoplasm	0.000338	0.00709	CbGpPWpGaD
Mitotane—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000335	0.000351	CcSEcCtD
Mitotane—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000332	0.000349	CcSEcCtD
Mitotane—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000326	0.000342	CcSEcCtD
Mitotane—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000311	0.000326	CcSEcCtD
Mitotane—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.00031	0.000325	CcSEcCtD
Mitotane—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000302	0.000317	CcSEcCtD
Mitotane—FDX1—Metabolism—BCHE—peripheral nervous system neoplasm	0.0003	0.0063	CbGpPWpGaD
Mitotane—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.0003	0.000315	CcSEcCtD
Mitotane—CYP11B1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000289	0.00607	CbGpPWpGaD
Mitotane—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000289	0.000303	CcSEcCtD
Mitotane—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000288	0.000302	CcSEcCtD
Mitotane—FDX1—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000287	0.00601	CbGpPWpGaD
Mitotane—Rash—Epirubicin—peripheral nervous system neoplasm	0.000286	0.000301	CcSEcCtD
Mitotane—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000286	0.0003	CcSEcCtD
Mitotane—Headache—Epirubicin—peripheral nervous system neoplasm	0.000285	0.000299	CcSEcCtD
Mitotane—FDX1—Metabolism—TH—peripheral nervous system neoplasm	0.000282	0.00593	CbGpPWpGaD
Mitotane—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000278	0.000292	CcSEcCtD
Mitotane—Nausea—Epirubicin—peripheral nervous system neoplasm	0.00027	0.000283	CcSEcCtD
Mitotane—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000267	0.000281	CcSEcCtD
Mitotane—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000265	0.000278	CcSEcCtD
Mitotane—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000265	0.000278	CcSEcCtD
Mitotane—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000263	0.000276	CcSEcCtD
Mitotane—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.00025	0.000262	CcSEcCtD
Mitotane—CYP11A1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000247	0.00519	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.00024	0.00504	CbGpPWpGaD
Mitotane—FDX1—Metabolism—GNAS—peripheral nervous system neoplasm	0.000231	0.00484	CbGpPWpGaD
Mitotane—FDX1—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000226	0.00475	CbGpPWpGaD
Mitotane—CYP11B1—Corticotropin-releasing hormone—AKT1—peripheral nervous system neoplasm	0.000214	0.00449	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—GNS—peripheral nervous system neoplasm	0.000209	0.00439	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.000206	0.00431	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—NME1—peripheral nervous system neoplasm	0.0002	0.00421	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—COX2—peripheral nervous system neoplasm	0.000193	0.00405	CbGpPWpGaD
Mitotane—CYP11A1—Corticotropin-releasing hormone—AKT1—peripheral nervous system neoplasm	0.000183	0.00384	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—GNS—peripheral nervous system neoplasm	0.000179	0.00375	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—NME1—peripheral nervous system neoplasm	0.000171	0.0036	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—COX2—peripheral nervous system neoplasm	0.000165	0.00346	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—ENO2—peripheral nervous system neoplasm	0.000127	0.00266	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—ENO2—peripheral nervous system neoplasm	0.000108	0.00227	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—BCHE—peripheral nervous system neoplasm	0.000107	0.00225	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000102	0.00214	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—TH—peripheral nervous system neoplasm	0.000101	0.00211	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—BCHE—peripheral nervous system neoplasm	9.16e-05	0.00192	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.73e-05	0.00183	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—TH—peripheral nervous system neoplasm	8.61e-05	0.00181	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—GNAS—peripheral nervous system neoplasm	8.22e-05	0.00172	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—ABCB1—peripheral nervous system neoplasm	8.06e-05	0.00169	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—GNAS—peripheral nervous system neoplasm	7.03e-05	0.00147	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—ABCB1—peripheral nervous system neoplasm	6.9e-05	0.00145	CbGpPWpGaD
Mitotane—FDX1—Metabolism—AKT1—peripheral nervous system neoplasm	6.22e-05	0.00131	CbGpPWpGaD
Mitotane—CYP11B1—Metabolism—AKT1—peripheral nervous system neoplasm	2.22e-05	0.000465	CbGpPWpGaD
Mitotane—CYP11A1—Metabolism—AKT1—peripheral nervous system neoplasm	1.9e-05	0.000398	CbGpPWpGaD
